Cite
APA Citation
Sambo, M. (n.d.). use of multikinase inhibitors/lenvatinib in patients with synchronous/metachronous cancers coinciding with radioactive‐resistant differentiated thyroid cancer. Cancer medicine, 11, 26–32. http://access.bl.uk/ark:/81055/vdc_100167908403.0x000019